Envestnet Asset Management’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$101K Sell
29,040
-3,536
-11% -$13.5K ﹤0.01% 4624
2025
Q4
$113K Buy
+32,576
New +$145K ﹤0.01% 4356
2025
Q2
Sell
-23,515
Closed -$46.8K 4531
2025
Q1
$46.8K Buy
23,515
+1,958
+9% +$5K ﹤0.01% 4298
2024
Q4
$62.9K Sell
21,557
-6,798
-24% -$23.9K ﹤0.01% 4251
2024
Q3
$110K Buy
28,355
+6,695
+31% +$31K ﹤0.01% 4126
2024
Q2
$111K Sell
21,660
-1,220
-5% -$7.4K ﹤0.01% 4042
2024
Q1
$160K Buy
22,880
+510
+2% +$3.87K ﹤0.01% 3992
2023
Q4
$198K Buy
22,370
+5,754
+35% +$44.3K ﹤0.01% 3830
2023
Q3
$159K Buy
+16,616
New +$216K ﹤0.01% 3783

Other funds holding PRME